Publication

Human GRIN2B variants in neurodevelopmental disorders

Downloadable Content

Persistent URL
Last modified
  • 02/25/2025
Type of Material
Authors
    Chun Hu, Emory UniversityWenjuan Chen, Emory UniversityScott J. Myers, Emory UniversityHongjie Yuan, Emory UniversityStephen Traynelis, Emory University
Language
  • English
Date
  • 2016-10-19
Publisher
  • Elsevier: Creative Commons Attribution Non-Commercial No-Derivatives License
Publication Version
Copyright Statement
  • © 2016 The Authors
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1347-8613
Volume
  • 132
Issue
  • 2
Start Page
  • 115
End Page
  • 121
Grant/Funding Information
  • This work was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R01HD082373 to H.Y), the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000454 to H.Y), and the National Institute of Neurological Disorders and Stroke (NS036654 to S.F.T.).
Abstract
  • The development of whole exome/genome sequencing technologies has given rise to an unprecedented volume of data linking patient genomic variability to brain disorder phenotypes. A surprising number of variants have been found in the N-methyl-D-aspartate receptor (NMDAR) gene family, with the GRIN2B gene encoding the GluN2B subunit being implicated in many cases of neurodevelopmental disorders, which are psychiatric conditions originating in childhood and include language, motor, and learning disorders, autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), developmental delay, epilepsy, and schizophrenia. The GRIN2B gene plays a crucial role in normal neuronal development and is important for learning and memory. Mutations in human GRIN2B were distributed throughout the entire gene in a number of patients with various neuropsychiatric and developmental disorders. Studies that provide functional analysis of variants are still lacking, however current analysis of de novo variants that segregate with disease cases such as intellectual disability, developmental delay, ASD or epileptic encephalopathies reveal altered NMDAR function. Here, we summarize the current reports of disease-associated variants in GRIN2B from patients with multiple neurodevelopmental disorders, and discuss implications, highlighting the importance of functional analysis and precision medicine therapies.
Author Notes
  • Corresponding Author: Stephen F. Traynelis Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, GA 30322, USA. Fax: +1 404 727 0365. Email: strayne@emory.edu
Keywords
Research Categories
  • Biology, Neuroscience
  • Health Sciences, Pharmacology

Tools

Relations

In Collection:

Items